N-glycosylation of plant-produced recombinant proteins.

Curr Pharm Des 2013 ;19(31):5503-12

Wageningen University and Research Centre, Plant Research International, Droevendaalsesteeg 1, 6708 PB Wageningen, The Netherlands.

Plants are gaining increasingly acceptance as a production platform for recombinant proteins. One reason for this is their ability to carry out posttranslational protein modifications in a similar if not identical way as mammalian cells. The capability of plants to carry out human-like complex glycosylation is well known. Moreover, the targeted manipulation of the plant N-glycosylation pathway allows the production of proteins carrying largely homogeneous, human-type oligosaccharides. These outstanding results have placed plants in a favourable position compared to other eukaryotic expression systems. This review provides a comprehensive summary of the N-glycosylation of plant-produced recombinant proteins, the possible impact of plant-specific N-glycans on the human immune system, and recent advances in engineering the plant N-glycosylation pathway towards the synthesis of (complex) human-type glycan structures, highlighting challenges and achievements in the application of these powerful technologies.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612811319310006DOI Listing
March 2014
3 Reads

Publication Analysis

Top Keywords

recombinant proteins
12
n-glycosylation plant-produced
8
plant n-glycosylation
8
plant-produced recombinant
8
n-glycosylation pathway
8
targeted manipulation
4
manipulation plant
4
pathway allows
4
production proteins
4
allows production
4
synthesis complex
4
pathway synthesis
4
complex human-type
4
human-type glycan
4
human-like complex
4
carry human-like
4
complex glycosylation
4
impact plant-specific
4
n-glycans human
4
glycosylation well
4

Similar Publications